← SynDRA
TANZISERTIB
SynDRA canonical compound SYN0028711 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | JNK inhibitor |
|---|
All known targets
- MAPK10
- MAPK8
- MAPK8; MAPK9; MAPK10
- MAPK9
Mechanisms of action (all sources)
- MAPK8 INHIBITOR
- c-Jun N-terminal kinase 1 inhibitor
- MAPK9 INHIBITOR
- c-Jun N-terminal kinase 2 inhibitor
- MAPK10 INHIBITOR
- c-Jun N-terminal kinase 3 inhibitor
- Modulator
Cross-references
Synonyms
- CC-930
- JNK-930
- JNK930
- CC 930
- UNII-M5O06306UO
- CHEMBL1950289
- M5O06306UO
- CC930
- Trans-4-({9-[(3s)-Tetrahydrofuran-3-Yl]-8-[(2,4,6-Trifluorophenyl)amino]-9h-Purin-2-Yl}amino)cyclohexanol
- Tanzisertib [USAN:INN]
- 3tti
- trans-4-((9-((3S)-Tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol
- Tanzisertib (USAN)
- CC-930(Tanzisertib)
- SCHEMBL2133061
- SCHEMBL4760419
- SCHEMBL2133055
- GTPL9836
- SCHEMBL8082102
- SCHEMBL15589918
- CHEMBL1950305
- SCHEMBL10179476
- MolPort-044-562-358
- RefChem:918157
- Tanzisertib [USAN]
- JNK 930
- C21H23F3N6O2
- JNK-930; JNKI-1
- MFCD23160040
- TANZISERTIB [INN]
- CC-930(Tanzisertib)?
- orb1308483
- SCHEMBL2138755
- SCHEMBL2138766
- SCHEMBL2138776
- SCHEMBL2604921
- GLXC-10800
- EX-A3115
Look up TANZISERTIB in the interactive SynDRA portal →